The impact of two decision aids for individuals considering genetic testing for hereditary breast/ovarian cancer or hereditary non-polyposis colorectal cancer (HNPCC) on psychological and decision-related outcomes.

Dr. Bettina Meiser0 个研究点目标入组 140 人开始时间: 2005年10月4日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•To be eligible to participate in the study, patients must meet all the following criteria: (i) be at potentially high risk of breast/ovarian cancer (family history consistent with hereditary breast/ovarian cancer syndrome [National Breast Cancer Centre Category 3]) or HNPCC (family history consistent with HNPCC according to the revised Amsterdam criteria); (ii) be eligible for genetic testing, that is either be affected with cancer or, if unaffected, have a living, affected relative for whom mutation search would be appropriate; (iii) be able to give informed consent; (iv) be able to read English proficiently.
•Men from HNPCC families will be included because the larger number of them (compared to breast/ovarian cancer families) will enable meaningful statistical analysis of their responses.

•Men from breast cancer families will not be invited to participate because of the low number of men attending familial cancer clinics and because of the substantial differences in the needs of men attending these clinics compared to women.

发起方

Dr. Bettina Meiser